PE  Linden

     Office Locations:

150 N Riverside Plaza, Suite 5100
Chicago, IL 60606
Phone: 312-506-5600
Fax: 312-506-5601



  • Middle Market



  • Life Sciences & Healthcare



    Formed in 2002, Linden is a healthcare and life sciences private equity firm that builds value in mature businesses. Linden's investment strategy is to purchase controlling equity interests in privately held companies and non-core businesses that can benefit from strategic redirection, operational improvements, acquisitions and additions to the management team. Linden invests primarily in leveraged buyouts or other late-stage transactions where it can be the lead investor or otherwise have significant governance influence. Linden does not make venture capital investments. Currently, Linden manages $3 billion in assets augmented by capital provided by their Limited Partners for larger transactions. To invest in mature companies of all sizes, Linden formed an alliance with Madison Dearborn Partners (see profile) to pursue large healthcare and life science buyout transactions (transactions requiring more than $50 million in private equity capital). Linden pursues smaller transactions (requiring less than $50 million in private equity capital) using its own funds.



      Fund Name



    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Anthony B. Davis Managing Partner and President
    Brian C. Miller Managing Partner
    Douglass W. VanDegrift CFO and CCO
    Joshua M. Reilly Principal
    Kam N. Shah Partner


    Portfolio companies include:


    Recent News: